Stephen E. Chang

No ORCID on file · 1 paper in corpus · active 2025
2025
·doi:10.64898/2025.12.06.692775

Rationale Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, are increasingly utilized in clinical practice due to their efficacy in promoting sustained weight loss following chronic administration. While acute treatme…